<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN" "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article article-type="research-article" dtd-version="1.4" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">odmj</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">OncoDaily Medical Journal</journal-title>
        <abbrev-journal-title abbrev-type="publisher">ODMJ</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">3067-6444</issn>
      <publisher>
        <publisher-name>OncoDaily Medical Journal</publisher-name>
        <publisher-loc>
          <country>US</country>
        </publisher-loc>
      </publisher>
      <self-uri xlink:href="https://oncodailyjournal.com/"/>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">4599</article-id>
      <article-id pub-id-type="doi">10.69690/ODMJ-001-0809-4599</article-id>
      <article-categories>
        <subj-group xml:lang="en" subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Survival Outcomes of Wilms&apos; Tumor in Pediatric Patients Treated at KFMC: A Retrospective Study of 15 years from 2007-2022</article-title>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Alnour</surname>
            <given-names>Omer</given-names>
          </name>
          <aff xml:lang="en">King Fahad Medical City</aff>
          <email>omeralnour2009@gmail.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rayis</surname>
            <given-names>Mohammed</given-names>
          </name>
          <aff xml:lang="en">King Fahad Medical City</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Almanjomi</surname>
            <given-names>Fahad</given-names>
          </name>
          <aff xml:lang="en">King Fahad Medical City</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khan</surname>
            <given-names>Zaheer Ullah</given-names>
          </name>
          <aff xml:lang="en">King Fahad Medical City</aff>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>09</day>
        <month>08</month>
        <year>2025</year>
      </pub-date>
      <elocation-id>ODMJ-001-0809-4599</elocation-id>
      <permissions>
        <copyright-statement>Copyright (c) 2025 OncoDaily Medical Journal</copyright-statement>
        <copyright-year>2025</copyright-year>
        <copyright-holder>OncoDaily Medical Journal</copyright-holder>
      </permissions>
      <self-uri xlink:href="https://oncodailyjournal.com/10.69690/odmj-001-0809-4599/"/>
      <kwd-group xml:lang="en">
        <kwd>pediatric oncology</kwd>
        <kwd>Wilms&apos; tumor</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>production-ready-file-url</meta-name>
          <meta-value>
            <ext-link ext-link-type="uri" xlink:href="https://oncodailyjournal.com/pub/uploads/2025/08/Survival-Outcomes-of-Wilms-.pdf"/>
          </meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body/>
  <back>
    <ref-list>
      <ref id="R1">
        <mixed-citation>Groenendijk A, Spreafico F, de Krijger RR, et al. Prognostic factors for Wilms tumor recurrence: a review of the literature. Cancers (Basel). 2021 Jun 23;13(13):3142.</mixed-citation>
      </ref>
      <ref id="R2">
        <mixed-citation>Zhu S, Hu J, Cui Y, et al. Knockdown of SENP1 inhibits HIF-1α SUMOylation and suppresses oncogenic CCNE1 in Wilms tumor. Mol Ther Oncolytics. 2021 Jul 21;23:355-66.</mixed-citation>
      </ref>
      <ref id="R3">
        <mixed-citation>Dome JS, Mullen EA, Dix DB, et al. Impact of the first generation of Children’s Oncology Group clinical trials on clinical practice for Wilms tumor. J Natl Compr Canc Netw. 2021 Aug 1;19(8):978-85.</mixed-citation>
      </ref>
      <ref id="R4">
        <mixed-citation>Gooskens SL, Segers H, Pritchard-Jones K, et al. The clinical relevance of age at presentation in nephroblastoma. In: van den Heuvel-Eibrink MM, editor. Wilms tumor [Internet]. Brisbane (AU): Codon Publications; 2016 Mar. Chapter 2.</mixed-citation>
      </ref>
      <ref id="R5">
        <mixed-citation>Bhutani N, Kajal P, Sharma U, et al. Many faces of Wilms tumor: recent advances and future directions. Ann Med Surg (Lond). 2021 Mar 7;64:102202.</mixed-citation>
      </ref>
      <ref id="R6">
        <mixed-citation>Jablonowski CM, Gil HJ, Pinto EM, et al. TERT expression in Wilms tumor is regulated by promoter mutation or hypermethylation, WT1, and N-MYC. Cancers (Basel). 2022 Mar 25;14(7):1655.</mixed-citation>
      </ref>
      <ref id="R7">
        <mixed-citation>Meier CM, Furtwängler R, Mergen M, et al. Impact of time to surgery on outcome in Wilms tumor treated with preoperative chemotherapy. Cancers (Basel). 2023 Feb 27;15(5):1494.</mixed-citation>
      </ref>
      <ref id="R8">
        <mixed-citation>Spreafico F, Fernandez CV, Brok J, et al. Wilms tumour. Nat Rev Dis Primers. 2021 Oct 14;7(1):75.</mixed-citation>
      </ref>
      <ref id="R9">
        <mixed-citation>Axt J, Abdallah F, Axt M, et al. Wilms tumor survival in Kenya. J Pediatr Surg. 2013 Jun;48(6):1254-62.</mixed-citation>
      </ref>
      <ref id="R10">
        <mixed-citation>Tan X, Wang J, Tang J, et al. A nomogram for predicting cancer-specific survival in children with Wilms tumor: a study based on SEER database and external validation in China. Front Public Health. 2022 Apr 7;10:829840.</mixed-citation>
      </ref>
      <ref id="R11">
        <mixed-citation>Abdel-Monem MM, El-Khawaga OY, Awadalla AA, et al. Gene expression analysis and the risk of relapse in favorable histology Wilms’ tumor. Arab J Urol. 2022 Sep 26;21(1):45-51.</mixed-citation>
      </ref>
      <ref id="R12">
        <mixed-citation>Fichera G, Bisogno G, Affinita MC, et al. Lung relapse pattern in children with metastatic Wilms tumor. Pediatr Blood Cancer. 2024 Apr;71(4):e30856.</mixed-citation>
      </ref>
      <ref id="R13">
        <mixed-citation>Charlton J, Irtan S, Bergeron C, et al. Bilateral Wilms tumour: a review of clinical and molecular features. Expert Rev Mol Med. 2017 Jul 18;19:e8.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
